Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus clobazam for prevention of recurrent febrile seizures
IRCT20210911052441N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levetiracetam and clobazam in febrile seizure (FS) (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoint: Incidence of febrile convulsion. Started Mar 2021; status: completed.
02
Drugs
levetiracetamclobazam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20210911052441N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210911052441N1.